Efficacy and safety of longer-term administration of evolocumab (AMG 145) in patients with hypercholesterolemia: 52-week results from the Open-Label Study of Long-Term Evaluation Against LDL-C (OSLER) randomized trial (Q38440924)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q59559995)
(Q57398724)
(Q57228807)
(P304) 234-243
(P407) (Q1860)
(P433) 2
(P478) 129
(P577) Tuesday, November 19, 2013
(P921) (Q762713)
(P1433) (Q578091)
(P1476) "Efficacy and safety of longer-term administration of evolocumab (AMG 145) in patients with hypercholesterolemia: 52-week results from the Open-Label Study of Long-Term Evaluation Against LDL-C (OSLER) randomized trial" (language: en)
(P2093) Michael J Koren
David Sullivan
Michael Bolognese
Gisle Langslet
Fernando Civeira
Ransi Somaratne
Patric Nelson
Thomas Liu
Scott M Wasserman
Marc S Sabatine
OSLER Investigators
other details
description scientific article

External Links